Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI)

0.602
Delayed Data
As of Aug 23
 +0.0219 / +3.78%
Today’s Change
0.46
Today|||52-Week Range
3.38
-50.25%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2008

2009

2010

2011
Revenue and IncomeNet Revenues0.0025.5M13.6M5.5M
 
 
 
 
Depreciation And Amortization89.0K50.0K52.0K75.0K
 
 
 
 
 
 
Operating ExpensesGross Income----13.6M5.4M
 
 
 
General Expenses11.0M24.1M24.3M27.7M
 
 
 
 
 
Research And Development7.8M20.2M18.5M21.6M
 
 
 
 
 
Total Operating Expenses11.1M24.2M24.3M27.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-11.1M1.4M-10.7M-22.3M
 
 
 
 
 
Extraordinary Credit--0.0096.0K7.4M
 
 
 
Extraordinary Charge---4.0M-5.1M0.00
 
 
 
Other Expenses211.0K70.0K6.0K6.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-10.7M-2.5M-15.6M-14.7M
 
 
 
 
 
Income Taxes-2.1M-3.0M-3.0M0.00
 
 
 
 
Preferred Dividend-2.0M0.000.000.00
 
 
Extraordinary Items-4.4M0.000.000.00
 
 
Net Income-8.6M-5.5M-12.6M-14.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS1.8M5.8M7.0M9.7M
 
 
 
 
 
Shares To Calculate EPS Diluted1.8M5.8M7.0M9.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$5.80-$0.95-$1.79-$1.51
 
 
 
 
 
EPS Diluted-$5.80-$0.95-$1.79-$1.51